CETP Gets Another Go: NewAmsterdam Phase III Trial Shows Safety And Efficacy
Executive Summary
The first Phase III trial testing the oral CETP inhibitor obicetrapib for the treatment of high cholesterol read out positively, years after some other drugs in the class failed.